Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Follicular 2 Pain 1 Neoplasms 1 Mucositis 1 Inflammation 1 Head and Neck Neoplasms 1 Cachexia 1 Breast Neoplasms 1 Breast Diseases 1 Agnosia 1 Abnormalities, Radiation-Induced 1

Interventions

Megestrol Acetate 5 anamorelin 1 Standard of Care 1 Radiotherapy 1 Olanzapine 1 Melatonin 1 Infliximab 1 Ibuprofen 1 Etanercept 1 Eicosapentaenoic Acid 1 Docetaxel 1 Dietary Supplements 1 Cyproheptadine 1 Creatine 1 Counseling 1 Caseins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cachexia × Ibuprofen × Clear all

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡